275 related articles for article (PubMed ID: 26848868)
1. Regulation of androgen receptor splice variant AR3 by PCGEM1.
Zhang Z; Zhou N; Huang J; Ho TT; Zhu Z; Qiu Z; Zhou X; Bai C; Wu F; Xu M; Mo YY
Oncotarget; 2016 Mar; 7(13):15481-91. PubMed ID: 26848868
[TBL] [Abstract][Full Text] [Related]
2. Androgen receptor splice variant AR3 promotes prostate cancer via modulating expression of autocrine/paracrine factors.
Sun F; Chen HG; Li W; Yang X; Wang X; Jiang R; Guo Z; Chen H; Huang J; Borowsky AD; Qiu Y
J Biol Chem; 2014 Jan; 289(3):1529-39. PubMed ID: 24297183
[TBL] [Abstract][Full Text] [Related]
3. ASC-J9 suppresses castration-resistant prostate cancer growth through degradation of full-length and splice variant androgen receptors.
Yamashita S; Lai KP; Chuang KL; Xu D; Miyamoto H; Tochigi T; Pang ST; Li L; Arai Y; Kung HJ; Yeh S; Chang C
Neoplasia; 2012 Jan; 14(1):74-83. PubMed ID: 22355276
[TBL] [Abstract][Full Text] [Related]
4. Vav3 enhances androgen receptor splice variant activity and is critical for castration-resistant prostate cancer growth and survival.
Peacock SO; Fahrenholtz CD; Burnstein KL
Mol Endocrinol; 2012 Dec; 26(12):1967-79. PubMed ID: 23023561
[TBL] [Abstract][Full Text] [Related]
5. A novel androgen receptor splice variant is up-regulated during prostate cancer progression and promotes androgen depletion-resistant growth.
Guo Z; Yang X; Sun F; Jiang R; Linn DE; Chen H; Chen H; Kong X; Melamed J; Tepper CG; Kung HJ; Brodie AM; Edwards J; Qiu Y
Cancer Res; 2009 Mar; 69(6):2305-13. PubMed ID: 19244107
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of the androgen receptor splicing in prostate cancer cells.
Liu LL; Xie N; Sun S; Plymate S; Mostaghel E; Dong X
Oncogene; 2014 Jun; 33(24):3140-50. PubMed ID: 23851510
[TBL] [Abstract][Full Text] [Related]
7. Androgen receptor splice variants contribute to prostate cancer aggressiveness through induction of EMT and expression of stem cell marker genes.
Kong D; Sethi S; Li Y; Chen W; Sakr WA; Heath E; Sarkar FH
Prostate; 2015 Feb; 75(2):161-74. PubMed ID: 25307492
[TBL] [Abstract][Full Text] [Related]
8. Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor.
Watson PA; Chen YF; Balbas MD; Wongvipat J; Socci ND; Viale A; Kim K; Sawyers CL
Proc Natl Acad Sci U S A; 2010 Sep; 107(39):16759-65. PubMed ID: 20823238
[TBL] [Abstract][Full Text] [Related]
9. A long noncoding RNA connects c-Myc to tumor metabolism.
Hung CL; Wang LY; Yu YL; Chen HW; Srivastava S; Petrovics G; Kung HJ
Proc Natl Acad Sci U S A; 2014 Dec; 111(52):18697-702. PubMed ID: 25512540
[TBL] [Abstract][Full Text] [Related]
10. The long non-coding RNA PCGEM1 is regulated by androgen receptor activity in vivo.
Parolia A; Crea F; Xue H; Wang Y; Mo F; Ramnarine VR; Liu HH; Lin D; Saidy NR; Clermont PL; Cheng H; Collins C; Wang Y; Helgason CD
Mol Cancer; 2015 Feb; 14():46. PubMed ID: 25744782
[TBL] [Abstract][Full Text] [Related]
11. Rapid induction of androgen receptor splice variants by androgen deprivation in prostate cancer.
Yu Z; Chen S; Sowalsky AG; Voznesensky OS; Mostaghel EA; Nelson PS; Cai C; Balk SP
Clin Cancer Res; 2014 Mar; 20(6):1590-600. PubMed ID: 24449822
[TBL] [Abstract][Full Text] [Related]
12. AR intragenic deletions linked to androgen receptor splice variant expression and activity in models of prostate cancer progression.
Li Y; Hwang TH; Oseth LA; Hauge A; Vessella RL; Schmechel SC; Hirsch B; Beckman KB; Silverstein KA; Dehm SM
Oncogene; 2012 Nov; 31(45):4759-67. PubMed ID: 22266865
[TBL] [Abstract][Full Text] [Related]
13. NF-κB2/p52:c-Myc:hnRNPA1 Pathway Regulates Expression of Androgen Receptor Splice Variants and Enzalutamide Sensitivity in Prostate Cancer.
Nadiminty N; Tummala R; Liu C; Lou W; Evans CP; Gao AC
Mol Cancer Ther; 2015 Aug; 14(8):1884-95. PubMed ID: 26056150
[TBL] [Abstract][Full Text] [Related]
14. Androgen receptor splice variant-7 expression emerges with castration resistance in prostate cancer.
Sharp A; Coleman I; Yuan W; Sprenger C; Dolling D; Rodrigues DN; Russo JW; Figueiredo I; Bertan C; Seed G; Riisnaes R; Uo T; Neeb A; Welti J; Morrissey C; Carreira S; Luo J; Nelson PS; Balk SP; True LD; de Bono JS; Plymate SR
J Clin Invest; 2019 Jan; 129(1):192-208. PubMed ID: 30334814
[TBL] [Abstract][Full Text] [Related]
15. Regulation of PCGEM1 by p54/nrb in prostate cancer.
Ho TT; Huang J; Zhou N; Zhang Z; Koirala P; Zhou X; Wu F; Ding X; Mo YY
Sci Rep; 2016 Sep; 6():34529. PubMed ID: 27682980
[TBL] [Abstract][Full Text] [Related]
16. Dysregulation of miR-212 Promotes Castration Resistance through hnRNPH1-Mediated Regulation of AR and AR-V7: Implications for Racial Disparity of Prostate Cancer.
Yang Y; Jia D; Kim H; Abd Elmageed ZY; Datta A; Davis R; Srivastav S; Moroz K; Crawford BE; Moparty K; Thomas R; Hudson RS; Ambs S; Abdel-Mageed AB
Clin Cancer Res; 2016 Apr; 22(7):1744-56. PubMed ID: 26553749
[TBL] [Abstract][Full Text] [Related]
17. Androgen receptor and its splice variant, AR-V7, differentially regulate FOXA1 sensitive genes in LNCaP prostate cancer cells.
Krause WC; Shafi AA; Nakka M; Weigel NL
Int J Biochem Cell Biol; 2014 Sep; 54():49-59. PubMed ID: 25008967
[TBL] [Abstract][Full Text] [Related]
18. The Role of Crosstalk between AR3 and E2F1 in Drug Resistance in Prostate Cancer Cells.
Xu J; Yang X; Deshmukh D; Chen H; Fang S; Qiu Y
Cells; 2020 Apr; 9(5):. PubMed ID: 32354165
[TBL] [Abstract][Full Text] [Related]
19. Preclinical Study using Malat1 Small Interfering RNA or Androgen Receptor Splicing Variant 7 Degradation Enhancer ASC-J9
Wang R; Sun Y; Li L; Niu Y; Lin W; Lin C; Antonarakis ES; Luo J; Yeh S; Chang C
Eur Urol; 2017 Nov; 72(5):835-844. PubMed ID: 28528814
[TBL] [Abstract][Full Text] [Related]
20. Histone demethylase JMJD1A promotes alternative splicing of AR variant 7 (AR-V7) in prostate cancer cells.
Fan L; Zhang F; Xu S; Cui X; Hussain A; Fazli L; Gleave M; Dong X; Qi J
Proc Natl Acad Sci U S A; 2018 May; 115(20):E4584-E4593. PubMed ID: 29712835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]